CYTK

Cytokinetics, Incorporated News Headlines

$4.07
*  
0.21
4.91%
Get CYTK Alerts
*Delayed - data as of Sep. 2, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Orphan Status for Insmed's Arikace - Analyst Blog
4/4/2013 4:07:41 PM - Zacks.com

ARNA/Eisai's Belviq Filed in Mexico - Analyst Blog
4/3/2013 4:19:58 PM - Zacks.com

Elan Sells Off Tysabri Stake - Analyst Blog
4/3/2013 2:21:56 PM - Zacks.com

BioMarin Files CTA for BMN-190 - Analyst Blog
4/3/2013 10:22:52 AM - Zacks.com

Vivus Opts for Royalty Financing - Analyst Blog
4/2/2013 7:21:59 PM - Zacks.com

Isis Publishes Encouraging Data - Analyst Blog
4/2/2013 5:25:30 PM - Zacks.com

Celgene Reaches 52-Week High - Analyst Blog
4/2/2013 10:08:11 AM - Zacks.com

Cytokinetics Growth-By-Partnership Strategy Looks Viable When It Comes To CK-2127107
4/2/2013 3:27:00 AM - Seeking Alpha

ANTH's Blisibimod Enters Phase III - Analyst Blog
4/1/2013 7:11:38 PM - Zacks.com

Gilead's HCV Study to Continue - Analyst Blog
4/1/2013 5:05:01 PM - Zacks.com

Bad News for Alexion, Shares Down - Analyst Blog
4/1/2013 4:07:41 PM - Zacks.com

Omeros Progresses with OMS824 - Analyst Blog
3/28/2013 7:26:44 PM - Zacks.com

Takeda Seeks Japanese Approval - Analyst Blog
3/28/2013 6:31:05 PM - Zacks.com

Balanced View on Gilead Sciences - Analyst Blog
3/28/2013 6:26:33 PM - Zacks.com

Setback for Idenix Pharma - Analyst Blog
3/28/2013 6:24:42 PM - Zacks.com

LabCorp Remains at Neutral - Analyst Blog
3/28/2013 4:31:17 PM - Zacks.com

LIFE Explores China's Growth Potential - Analyst Blog
3/28/2013 3:28:46 PM - Zacks.com

Affymetrix Inks Deal with UK Biobank - Analyst Blog
3/28/2013 2:29:24 PM - Zacks.com

Takeda Files Adcetris in Japan - Analyst Blog
3/27/2013 3:26:29 PM - Zacks.com

Acorda Reports Data on Epilepsy Drug - Analyst Blog
3/26/2013 4:27:57 PM - Zacks.com

Integra's Second Cobalt Chrome Rod - Analyst Blog
3/26/2013 4:25:44 PM - Zacks.com

Zimmer Optimistic About New Product - Analyst Blog
3/26/2013 4:17:01 PM - Zacks.com

CHMP Negative on Gentium Candidate - Analyst Blog
3/26/2013 10:28:43 AM - Zacks.com

CHMP Positive on Ariad's Iclusig - Analyst Blog
3/25/2013 6:27:49 PM - Zacks.com

CHMP Still Negative on Isis' Kynamro - Analyst Blog
3/25/2013 5:32:02 PM - Zacks.com